<HashMap><database>biostudies-literature</database><scores/><additional><submitter>LaVergne SM</submitter><funding>Foundation for the National Institutes of Health</funding><pagination>e0010882</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9731491</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(11)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Lassa virus is a priority pathogen for vaccine research and development, however the duration of cellular immunity and protection in Lassa fever (LF) survivors remains unclear.&lt;h4>Methods&lt;/h4>We investigated Lassa virus specific CD8+ T cell responses in 93 LF survivors. Peripheral blood mononuclear cells from these individuals were infected with recombinant vesicular stomatitis virus encoding Lassa virus antigens and virus specific T cell responses were measured after 18-hour incubation. Participants who had undetectable CD8+ T cell response underwent further analysis using a 10-day T cell proliferation assays to evaluate for low T cell precursor frequency.&lt;h4>Results&lt;/h4>Forty-five of the 93 LF survivors did not have a Lassa virus specific CD8+ T cell response. Of tho</pubmed_abstract><journal>PLoS neglected tropical diseases</journal><pubmed_title>Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors.</pubmed_title><pmcid>PMC9731491</pmcid><funding_grant_id>1R01AI123535.</funding_grant_id><funding_grant_id>HHSN272201400048C</funding_grant_id><pubmed_authors>Grant DS</pubmed_authors><pubmed_authors>Oldstone MBA</pubmed_authors><pubmed_authors>Kanneh L</pubmed_authors><pubmed_authors>de la Torre JC</pubmed_authors><pubmed_authors>Sakabe S</pubmed_authors><pubmed_authors>Garry RF</pubmed_authors><pubmed_authors>Schieffelin JS</pubmed_authors><pubmed_authors>LaVergne SM</pubmed_authors><pubmed_authors>Sullivan BM</pubmed_authors><pubmed_authors>Momoh M</pubmed_authors><pubmed_authors>Bond N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors.</name><description>&lt;h4>Introduction&lt;/h4>Lassa virus is a priority pathogen for vaccine research and development, however the duration of cellular immunity and protection in Lassa fever (LF) survivors remains unclear.&lt;h4>Methods&lt;/h4>We investigated Lassa virus specific CD8+ T cell responses in 93 LF survivors. Peripheral blood mononuclear cells from these individuals were infected with recombinant vesicular stomatitis virus encoding Lassa virus antigens and virus specific T cell responses were measured after 18-hour incubation. Participants who had undetectable CD8+ T cell response underwent further analysis using a 10-day T cell proliferation assays to evaluate for low T cell precursor frequency.&lt;h4>Results&lt;/h4>Forty-five of the 93 LF survivors did not have a Lassa virus specific CD8+ T cell response. Of tho</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-22T11:18:18.811Z</modification><creation>2025-04-05T23:54:30.422Z</creation></dates><accession>S-EPMC9731491</accession><cross_references><pubmed>36441765</pubmed><doi>10.1371/journal.pntd.0010882</doi></cross_references></HashMap>